Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281629 · ClinicalTrials.gov registry record · NA
Circuitry-Guided Smoking Cessation in Schizophrenia
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03281629 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 44 participants.
The verdict
NCT03281629, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
In a double-blinded, randomized, parallel controlled design, patients with schizophrenia spectrum disorder will be exposed to active or sham repetitive transcranial magentic stimulation (TMS) which was guided by functional magnetic resonance image (MRI). Smoking reduction/cessation and brain functional connectivity changes will be assessed at baseline, different stages of rTMS and/or follow-ups.
Interventions
- DEVICE Active TMS stimulation
- DEVICE Sham TMS stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-10-19 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03281629
The ClinicalTrials.gov registry entry for NCT03281629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active TMS stimulation is the first listed.
NCT03281629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03281629 about?
NCT03281629 is a clinical study titled "Circuitry-Guided Smoking Cessation in Schizophrenia". In a double-blinded, randomized, parallel controlled design, patients with schizophrenia spectrum disorder will be exposed to active or sham repetitive transcranial magentic stimulation (TMS) which was guided by functional magnetic resonance image (MRI). Smoking reduction/cessation and brain functio...
What is the current status of trial NCT03281629?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2018-10-19. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT03281629?
The interventions under investigation include: Active TMS stimulation (DEVICE), Sham TMS stimulation (DEVICE).
Who is sponsoring clinical trial NCT03281629?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.